Xarelto Lawsuit An Incredibly Easy Method That Works For All
Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so might be grounds for compensation. Our lawyers are working difficult to obtain these hurt by the drug the compensation they are entitled to.
Whilst bleeding is really a typical complication linked with anticoagulants, it has been alleged that Xarelto is much more hazardous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, in the occasion of an emergency, individuals could be at risk for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging.
In the event you or even a loved 1 suffered a critical bleeding occasion right after taking Xarelto, you might have legal recourse. For much more details, contact us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto fda warning-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in situations of death, funeral expenses. In addition, they are seeking punitive damages, that are normally awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
